a combination of levodopa and the extracerebrally acting decarboxylase inhibitor benserazide ( ratio 4:1 ) ( madopar ) , was compared with levodopa alone in a controlled double-blind clinical multicenter trial on 94 patients with parkinson 's disease .
C0023570
levodopa
C0030567
parkinson 's disease